Lilly at a Glance
Founded May 10, 1876
Headquarters located in Indianapolis, Indiana, U.S.A and operates in 120 countries
Lilly introduced the world's first commercial insulin in 1923.
Approximately 34,000 employees worldwide.
More than 7,700 employees engaged in research and development.
Products marketed in 120 countries.
Research & Development
R&D expenses (2019) $21.5 million
R&D as a percentage of sales: 25.1%
Percentage of total workforce engaged in R&D: 23%
Research and development facilities located in 8 countries
Clinical research conducted in more than 55 countries
Manufacturing plants located in 8 countries
Approximately 33,000 employees worldwide
14, 707 employees in the US (Dec 2019)
18,917 employees outside US (Dec 2019)
669 employees in the UK (Sept 2019)
Percentage of women in management in the UK 41% (2019)
Racial and ethnic minority representation in management in the United States 21% (2018)
Raised $13.4 million for United Way through the generosity of our employees and retirees and a match from the Lilly Foundation. (2019)
19,000 young people received Lilly insulin donated through Life for a Child last year
35,000 people screened for breast and cervical cancer in Kenya through AMPATH partnership
1.2 million employee volunteer hours through Lilly Global Day of Service
Cost of Pharmaceuticals
Average cost to discover and develop a new drug: $2.6 billion
Average length of time from discovery to patient: 10 years